The quantitative determination of risedronate in urine by SPE-LC-MS-MS
Details for Australian Patent Application No. 2008222912 (hide)
International Classifications
Event Publications
1 October 2009 PCT application entered the National Phase
PCT publication WO2008/109632 Priority application(s): WO2008/109632
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008222926-Amelioration of cellular stress response
2008222910-Syringe assembly having disabling mechanism with tamper resistance features
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser